Keywords: TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BAL; bronchoalveolar lavage; ChIA-PET; chromatin interaction analysis with paired-end tag; ChIP-seq; chromatin inmunoprecipitation and massively parallel sequencing; circ-ncRNA; circulating noncoding RNA; CRC; colorectal cancer; CRISPR-Cas9; clustered, re
Keywords: Ac; Acetylated; APC; Adenomatous polyposis coli; CRC; Colorectal Cancer; CAV1; Caveolin-1; DNMT; DNA methyl transferase; DNMTi; DNA methyl transferase inhibitor; Dox; Doxycycline; H3/4; Histone3/4; HDAC; Histone deacetylase; HDACi; Histone deacetylase inh
Keywords: α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Keywords: BDNF; brain derived neurotrophic factor; CAMKII; calmodulin-dependent protein kinase II; Ca2+; calcium; cAMP; cyclic adenosine monophosphate; CBS; cystathionine-β-synthase; CCI; chronic constriction injury; CFA; complete Freund's adjuvant; cGMP; cyclic
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
Keywords: AICD; activation-induced cell death; AML; acute myeloid leukemia; APC; antigen-presenting cells; CAR; coxsackie- and adenovirus receptor; CDKs; cyclin-dependent kinases; CG; cancer germline; DCs; dendritic cells; HAT; histone acetyltransferase; HDAC; hist
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Keywords: BC; breast Cancer; ER; estrogen Receptor; PgR,PR; progesteron receptor; HER-2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancer; ncRNA; non coding RNA; CpG(s); cytosine-phosphate-guanine dinucleotide(s); 5-me-C; 5-methyl-cytos
Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells
Keywords: Liver Development; Differentiation; Hepatocyte; Culture; CRISPR; clustered regularly interspaced short palindromic repeats; CYP; cytochrome P450; 3D; 3-dimensional; DNMTi; DNA methylation inhibitor; ECM; extracellular matrix; ESC; embryonic stem cell; ES-
DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies
Keywords: DNMT; DNA methyltransferase; 5azadC; 5-aza-2â²-deoxycytidine; 5azaC; 5-azacytidine; SAM; S-adenosyl-l-methionine; SAH; S-adenosyl-l-homocysteine; DNMTi; DNMT inhibitors; HDACi; histone deacetylase inhibitors; CpGs; 5â²-CpG-3â² dinucleotides; CGis; CpG
Effect of DNMT inhibitor on bovine parthenogenetic embryo development
Keywords: DNMT; RG108; DNA methylation; Bovine parthenogenetic preimplantation embryos; DNMT; DNA methyltransferase; DNMTi; DNA methyltransferase inhibitor; P2; parthenogenetic 2-cell embryos; P4; parthenogenetic 4-cell embryos; P8; parthenogenetic 8-cell embryos;
Genome-wide effects of DNA methyltransferase inhibitor on gene expression in double-stranded RNA transfected porcine PK15 cells
Keywords: PK15; porcine kidney epithelial cell line; DNMTi; DNA methyltransferase inhibitor; Aza-CdR; DNA methyltransferase inhibitor 5-aza-2â²-deoxycytidine; Poly(I:C); a synthetic viral-like dsRNA analog plolyinosinic:polycyticdylic acid; A; PK15 cells treated w
Chromatin-modifying agents in anti-cancer therapy
Keywords: Epigenetic inhibitors; HDAC; DNMT; Anti-cancer therapy; Clinical trials; Combinatory treatments; AML; acute myeloid leukemia; AZA; 5-azacytidine; CMA; chromatin-modifying agent; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CTCL; c
Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells
Keywords: AML; acute myelogenous leukemia; DNMTI; DNA methyltransferase inhibitor; HDACI; histone deacetylase inhibitor; APL; acute promyelocytic leukemia; TP53; p21waf1; Caspase3; Mcl-1;
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
Keywords: Ovarian cancer; Epigenetics; Chemosensitization; Platinum resistance; DNMTI; HDAC inhibitor
The promises and pitfalls of epigenetic therapies in solid tumours
Keywords: Epigenetics; DNMTI; HDAC inhibitor; Pharmacodynamic; Biomarker; Solid tumour